In syngeneic mouse models, these cells selectively eliminated TAMs, resulting in a marked enrichment of pro-inflammatory macrophage subsets within the TME, enhanced CD8+ T cell infiltration, reduced tumour growth, and prolonged overall survival. The gene discussed is CD8A; the disease is neoplasm.